GENEVA, Nov. 24 -- SANOFI (46 avenue de la Grande Armee75017 Paris) filed a patent application (PCT/IB2025/000221) for "METHODS OF TREATING CANCER USING TRISPECIFIC BINDING PROTEINS TARGETING HER2-EXPRESSING TUMORS" on May 16, 2025. With publication no. WO/2025/238419, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ABBADESSA, Giovanni (c/o Sanofi, Patent Department 450 Water StreetCambridge, Massachusetts 02141), BUDAY, Barbara (c/o Sanofi-Aventis Deutschland GmbH65926 Frankfurt Am Main), MASCIARI, Serena (c/o Sanofi, Pa...